IJMS | Free Full-Text | Daily Lifestyle and Cutaneous Malignancies
Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus | Circulation
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines: Cell Systems
Publications | Dhanasekaran Lab | Stanford Medicine
Untitled
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention - ScienceDirect
Detecting anti–SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion | Science Advances
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy | Physiological Reviews
Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences | eLife
SARS-CoV-2 Antiviral Therapy | Clinical Microbiology Reviews
Medicina | Free Full-Text | Validation of Cognitive Rehabilitation as a Balance Rehabilitation Strategy in Patients with Parkinson's Disease: Study Protocol for a Randomized Controlled Trial
Antibody–Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers | Journal of the American Chemical Society
Advances and gaps in SARS-CoV-2 infection models | PLOS Pathogens
RAD51B in Familial Breast Cancer | PLOS ONE
Clinical Update: Cardiovascular Disease in Diabetes Mellitus | Circulation
A Highly Potent SARS-CoV-2 Blocking Lectin Protein | ACS Infectious Diseases
Enhanced SARS-CoV-2 neutralization by dimeric IgA | Science Translational Medicine
Experimental Hematology Group - VHIO
SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants | mBio
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection | Science Immunology
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV) | eLife
